EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Supratherapeutic drug concentration triggers: A novel data‐driven approach to assess their value for medication safety surveillance in intensive care

Anne Paulien Langermans iD, Izak A R Yasrebi-de Kom, Dylan Wayne de Lange, Nicolette Fransisca de Keizer, Joanna E Klopotowska iD, RESCUE Study group

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70610 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Anne Paulien Langermans und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Informatics, Amsterdam Public Health research institute, Amsterdam University Medical Centre, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Intensive Care Units, Drug-Related Side Effects and Adverse Reactions, Critical Care, Drug Monitoring. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research, ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Electronic triggers (e‐triggers) are used as screening signals to detect potential adverse drug events (ADEs) and offer an effective system level approach for medication safety surveillance. Their clinical utility is typically evaluated through time‐consuming manual chart review by experts, limiting implementation. Estimating associations between e‐triggers and relevant ICU patient outcomes may provide a rapid, data‐driven alternative. In this study, electronic supratherapeutic drug concentration triggers (eSDCT) were used as a use case.

Methods

Pseudonymized Electronic Health Record (EHR) data from adults admitted to 14 Dutch ICUs (2010–2020) were analysed. Patients with ≥1 therapeutic drug monitoring measurements were included. eSDCTs were selected based on literature, data availability and expert input. Associations with ICU Length of Stay (LOS), ICU mortality and hospital mortality were assessed using adjusted linear and logistic mixed‐effects models.

Results

Among 6006 ICU admissions, 49.5% ( n = 2973) had ≥1 of the five selected group‐level eSDCTs. Exposed admissions showed higher hospital mortality (38.2% vs . 27.9%), ICU mortality (30.6% vs . 20.3%) and longer ICU LOS (median 13.8 [IQR 5.6–28.1] vs . 7.5 [3.2–15.7] days) compared with unexposed admissions. After adjustment, antibiotic and immunosuppressive eSDCTs remained associated with increased ICU mortality (OR 1.47 [1.26–1.70] and 2.86 [1.56–5.24]), hospital mortality (OR 1.46 [1.27–1.68] and 1.81 [1.07–3.10]) and prolonged ICU LOS (expB 1.82 [1.71–1.94] and 2.99 [2.46–3.62]).

Conclusion

Our data‐driven approach shows that antibiotic and immunosuppressive eSDCTs are associated with worse ICU patient outcomes, supporting their implementation for ICU‐level medication safety surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intensive Care UnitsDrug-Related Side Effects and Adverse ReactionsCritical CareDrug MonitoringAdverse Drug Reaction Reporting SystemsHumansFemaleLength of StayAgedMiddle AgedHospital MortalityMaleNetherlandsElectronic Health RecordsAdult

Stichwörter der Autor:innen

adverse drug eventselectronic triggersintensive caremedication safetypatient outcomes

Autor:innen und Institutionen

  • Department of Medical Informatics, Amsterdam Public Health research institute, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
  • ChipSoft, Amsterdam, The Netherlands.
  • Department of Intensive Care and Dutch Poison Information Centre, University Medical Centre Utrecht, Utrecht, The Netherlands.

ORCID-Profile: Anne Paulien Langermans, Joanna E Klopotowska

Förderung

  • Health Research
  • ZonMw

Zitieren

APA

Langermans, A. P., Yasrebi-de Kom, I. A. R., de Lange, D. W., de Keizer, N. F., Klopotowska, J. E., & RESCUE Study group (2026). Supratherapeutic drug concentration triggers: A novel data‐driven approach to assess their value for medication safety surveillance in intensive care. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70610

Vancouver

Langermans AP, Yasrebi-de Kom IAR, de Lange DW, de Keizer NF, Klopotowska JE, RESCUE Study group. Supratherapeutic drug concentration triggers: A novel data‐driven approach to assess their value for medication safety surveillance in intensive care. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70610

BibTeX
@article{Langermans2026,
  author = {Langermans, Anne Paulien and Yasrebi-de Kom, Izak A R and de Lange, Dylan Wayne and de Keizer, Nicolette Fransisca and Klopotowska, Joanna E and RESCUE Study group, RESCUE Study group},
  title = {Supratherapeutic drug concentration triggers: A novel data‐driven approach to assess their value for medication safety surveillance in intensive care},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70610}
}
Kostenlos starten →